Type 1 diabetes: etiology, immunology, and therapeutic strategies

TL Van Belle, KT Coppieters… - Physiological …, 2011 - journals.physiology.org
Type 1 diabetes (T1D) is a chronic autoimmune disease in which destruction or damaging of
the beta-cells in the islets of Langerhans results in insulin deficiency and hyperglycemia. We …

Pancreatic β cell regeneration as a possible therapy for diabetes

C Aguayo-Mazzucato, S Bonner-Weir - Cell metabolism, 2018 - cell.com
Diabetes is the result of having inadequate supply of functional insulin-producing β cells.
Two possible approaches for replenishing the β cells are:(1) replacement by transplanting …

DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients

M Volkmar, S Dedeurwaerder, DA Cunha… - The EMBO …, 2012 - embopress.org
In addition to genetic predisposition, environmental and lifestyle factors contribute to the
pathogenesis of type 2 diabetes (T2D). Epigenetic changes may provide the link for …

Pancreatic exocrine duct cells give rise to insulin-producing β cells during embryogenesis but not after birth

M Solar, C Cardalda, I Houbracken, M Martín… - Developmental cell, 2009 - cell.com
A longstanding unsettled question is whether pancreatic β cells originate from exocrine duct
cells. We have now used genetic labeling to fate map embryonic and adult pancreatic duct …

[HTML][HTML] The role of gut hormones in glucose homeostasis

DJ Drucker - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
The gastrointestinal tract has a crucial role in the control of energy homeostasis through its
role in the digestion, absorption, and assimilation of ingested nutrients. Furthermore, signals …

Cholecystokinin and gastrin receptors

M Dufresne, C Seva, D Fourmy - Physiological reviews, 2006 - journals.physiology.org
Cholecystokinin and gastrin receptors (CCK1R and CCK2R) are G protein-coupled
receptors that have been the subject of intensive research in the last 10 years with …

New sources of pancreatic β-cells

S Bonner-Weir, GC Weir - Nature biotechnology, 2005 - nature.com
Two major initiatives are under way to correct the β-cell deficit of diabetes: one would
generate β-cells ex vivo that are suitable for transplantation, and the second would stimulate …

β-cell growth and regeneration: replication is only part of the story

S Bonner-Weir, WC Li, L Ouziel-Yahalom, L Guo… - Diabetes, 2010 - Am Diabetes Assoc
FIG. 1. Neogenesis in mouse pancreas. A: The metaplastic ducts seen in the zinc-treated
metallothionen. TGF-transgenic mice have 6% insulin (red, white arrows) cells and some …

The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the …

F Ezquer, M Ezquer, D Contador, M Ricca, V Simon… - Stem …, 2012 - academic.oup.com
Type 1 diabetes mellitus (T1DM) is a chronic metabolic disease that results from cell‐
mediated autoimmune destruction of insulin‐producing cells. In T1DM animal models, it has …

Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory …

I Boumaza, S Srinivasan, WT Witt… - Journal of …, 2009 - Elsevier
Cell-based therapies offer considerable promise for prevention or cure of diabetes. We
explored the potential of autologous, self-renewing, mesenchymal stem cells (MSC) as a …